Clinical Trial Site

Debrecen, Hajdú-Bihar 4032

2 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Uveitis, Uveitis, Intermediate, Uveitis, Posterior

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis — Running, not enrolling